SCP2
Sterol carrier protein 2
Also known as: SCP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P22307
- Gene
- SCP2
- Ensembl
- ENSG00000116171
- Chromosome
- 1
- Canonical length
- 547 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Peroxisomes
OverviewNCBI Gene
This gene encodes two proteins: sterol carrier protein X (SCPx) and sterol carrier protein 2 (SCP2), as a result of transcription initiation from 2 independently regulated promoters. The transcript initiated from the proximal promoter encodes the longer SCPx protein, and the transcript initiated from the distal promoter encodes the shorter SCP2 protein, with the 2 proteins sharing a common C-terminus. Evidence suggests that the SCPx protein is a peroxisome-associated thiolase that is involved in the oxidation of branched chain fatty acids, while the SCP2 protein is thought to be an intracellular lipid transfer protein. This gene is highly expressed in organs involved in lipid metabolism, and may play a role in Zellweger syndrome, in which cells are deficient in peroxisomes and have impaired bile acid synthesis. Alternative splicing of this gene produces multiple transcript variants, some encoding different isoforms.[provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
547 residues, UniProt reviewed canonical sequence.
>P22307|SCP2
1 MSSSPWEPAT LRRVFVVGVG MTKFVKPGAE NSRDYPDLAE EAGKKALADA QIPYSAVDQA
61 CVGYVFGDST CGQRAIYHSL GMTGIPIINV NNNCATGSTA LFMARQLIQG GVAECVLALG
121 FEKMSKGSLG IKFSDRTIPT DKHVDLLINK YGLSAHPVAP QMFGYAGKEH MEKYGTKIEH
181 FAKIGWKNHK HSVNNPYSQF QDEYSLDEVM ASKEVFDFLT ILQCCPTSDG AAAAILASEA
241 FVQKYGLQSK AVEILAQEMM TDLPSSFEEK SIIKMVGFDM SKEAARKCYE KSGLTPNDID
301 VIELHDCFST NELLTYEALG LCPEGQGATL VDRGDNTYGG KWVINPSGGL ISKGHPLGAT
361 GLAQCAELCW QLRGEAGKRQ VPGAKVALQH NLGIGGAVVV TLYKMGFPEA ASSFRTHQIE
421 AVPTSSASDG FKANLVFKEI EKKLEEEGEQ FVKKIGGIFA FKVKDGPGGK EATWVVDVKN
481 GKGSVLPNSD KKADCTITMA DSDFLALMTG KMNPQSAFFQ GKLKITGNMG LAMKLQNLQL
541 QPGNAKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SCP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 1,043 nTPM
Expression across tissuesHPA
Tissue
- liver: 1,043 nTPM
- duodenum: 316 nTPM
- kidney: 298 nTPM
- small intestine: 288 nTPM
- rectum: 254 nTPM
- colon: 241 nTPM
Single-cell type
- hepatocytes: 1,657 nCPM
- esophageal apical cells: 1,044 nCPM
- breast lactating cells: 765 nCPM
- enterocytes: 749 nCPM
- parietal cells: 624 nCPM
- foveolar cells: 536 nCPM
Immune cell
- total PBMC: 290 nTPM
- basophil: 287 nTPM
- eosinophil: 287 nTPM
- myeloid DC: 231 nTPM
- intermediate monocyte: 209 nTPM
- non-classical monocyte: 205 nTPM
Brain region
- choroid plexus: 80 nTPM
- white matter: 79 nTPM
- medulla oblongata: 76 nTPM
- hypothalamus: 73 nTPM
- spinal cord: 72 nTPM
- thalamus: 72 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SCP2.
Disease | AllUniProt
Conditions SCP2 is implicated in, by any mechanism.
- Leukoencephalopathy with dystonia and motor neuropathy (LKDMN) MIM:613724
Disease | GeneticClinVar
27 pathogenic / likely-pathogenic of 533 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Sterol carrier protein 2 deficiency
- SCP2-related disorder
- Hepatocellular carcinoma
- Ovarian cancer
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.26
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alpha-linolenic acid metabolic process
- bile acid biosynthetic process
- bile acid metabolic process
- fatty acid beta-oxidation
- fatty acid beta-oxidation using acyl-CoA oxidase
- fatty acid derivative biosynthetic process
- inositol trisphosphate biosynthetic process
- intracellular cholesterol transport
- lipid hydroperoxide transport
- long-chain fatty acid biosynthetic process
- phospholipid transport
- progesterone biosynthetic process
- protein localization to plasma membrane
- regulation of lipid metabolic process
- regulation of phospholipid biosynthetic process
- steroid biosynthetic process
- unsaturated fatty acid biosynthetic process
- positive regulation of intracellular cholesterol transport
- positive regulation of steroid metabolic process
Molecular functions
- acetyl-CoA C-acyltransferase activity
- acetyl-CoA C-myristoyltransferase activity
- cholesterol binding
- cholesterol transfer activity
- fatty-acyl-CoA binding
- long-chain fatty acyl-CoA binding
- oleic acid binding
- phosphatidylcholine transfer activity
- phosphatidylinositol transfer activity
- signaling receptor binding
- propanoyl-CoA C-acyltransferase activity
- propionyl-CoA C2-trimethyltridecanoyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SCP2 sterol-binding domain
- Thiolase-like
- Thiolase, conserved site
- Thiolase, acyl-enzyme intermediate active site
- Thiolase, N-terminal
- SCP2 sterol-binding domain superfamily
- Thiolase, N-terminal domain
- SCP-2 sterol transfer family
- Thiolase, C-terminal domain 2
- Thiolase C-terminal domain-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SCP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SCP2 as an antibody target. Whether an autoantibody or antibody against SCP2 could matter depends on whether native SCP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SCP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SCP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...